These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D. J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517 [Abstract] [Full Text] [Related]
3. Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. Wright RM, Moore JE, Shaw A, Dunbar K, Dodd M, Webb K, Redmond AO, Crowe M, Murphy PG, Peacock S, Elborn JS. J Clin Pathol; 2001 Oct; 54(10):803-5. PubMed ID: 11577134 [Abstract] [Full Text] [Related]
4. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. Kiska DL, Kerr A, Jones MC, Caracciolo JA, Eskridge B, Jordan M, Miller S, Hughes D, King N, Gilligan PH. J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102 [Abstract] [Full Text] [Related]
5. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A. J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579 [Abstract] [Full Text] [Related]
6. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. Shelly DB, Spilker T, Gracely EJ, Coenye T, Vandamme P, LiPuma JJ. J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992 [Abstract] [Full Text] [Related]
7. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Vu-Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg-Chenon A. Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562 [Abstract] [Full Text] [Related]
8. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Chest; 2000 Jun; 117(6):1661-5. PubMed ID: 10858399 [Abstract] [Full Text] [Related]
9. Comparison of four selective media for the isolation of Burkholderia mallei and Burkholderia pseudomallei. Glass MB, Beesley CA, Wilkins PP, Hoffmaster AR. Am J Trop Med Hyg; 2009 Jun; 80(6):1023-8. PubMed ID: 19478269 [Abstract] [Full Text] [Related]
11. Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli. Segonds C, Clavel-Batut P, Thouverez M, Grenet D, Le Coustumier A, Plésiat P, Chabanon G. J Clin Microbiol; 2009 May; 47(5):1510-6. PubMed ID: 19297595 [Abstract] [Full Text] [Related]
12. Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis. Maruri-Aransolo A, de Dios Caballero J, Michelena M, Medina-Pascual MJ, Carrasco G, Asensio O, Cols M, Cantón R, GEIFQ group. Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1349-1353. PubMed ID: 38780755 [Abstract] [Full Text] [Related]
13. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H, Vandamme P, Van Zeebroeck A, De Boeck K, Struelens MJ, Verhaegen J, Ursi JP, Verschraegen G, Franckx H, Malfroot A, Dab I, Lauwers S. Acta Clin Belg; 1996 Jul; 51(4):222-30. PubMed ID: 8858887 [Abstract] [Full Text] [Related]
14. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism. Moore JE, Millar BC, Xu J, Crowe M, Redmond AO, Elborn JS. J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219 [Abstract] [Full Text] [Related]
15. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. Kenna DTD, Lilley D, Coward A, Martin K, Perry C, Pike R, Hill R, Turton JF. J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663 [Abstract] [Full Text] [Related]
16. Is prolonged incubation required for optimal recovery of Burkholderia cepacia complex in sputum from cystic fibrosis patients? Data versus dogma. Naqvi S, Varadhan H, Givney R. Pathology; 2020 Apr; 52(3):366-369. PubMed ID: 32113671 [Abstract] [Full Text] [Related]
17. A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria. Vanlaere E, Coenye T, Samyn E, Van den Plas C, Govan J, De Baets F, De Boeck K, Knoop C, Vandamme P. FEMS Microbiol Lett; 2005 Aug 15; 249(2):303-7. PubMed ID: 16000240 [Abstract] [Full Text] [Related]
18. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. Whitby PW, Dick HL, Campbell PW, Tullis DE, Matlow A, Stull TL. J Clin Microbiol; 1998 Jun 15; 36(6):1642-5. PubMed ID: 9620393 [Abstract] [Full Text] [Related]
19. Identification of Burkholderia cepacia Complex by PCR: A Simple Way. Dufour G, Lebel K, Bellemare J, Iugovaz I. PDA J Pharm Sci Technol; 2023 Dec 07; 77(6):485-497. PubMed ID: 37451835 [Abstract] [Full Text] [Related]
20. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. J Clin Microbiol; 2000 Feb 07; 38(2):910-3. PubMed ID: 10655415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]